Enrollment data
That's why the stockholders need specific numbers on a regular basis. The number of patients enrolled in CD12 is the company's single most important metric with respect to the stock price at this point. If the number keeps going up at a reasonable pace, and you believe in the drug as I do, you are bullish. If you don't know if the progress is reasonable, you're bearish, no matter what your trust in the science is. If you've been holding the stock for a while, you will notice that the stock tends to drop in price when there is an information vacuum. Truthful information, even if not the best news, prevents the vacuum and raises corporate credibility. When the vacuum exists, people think the worst and sell.
CYDY can stay ahead of the field if the enrollment moves along. Most of us stockholders think the drug works. The question is what the competition will be when it gets its release. If the enrollment moves along, we'll stand alone for a while and will sell out the drug at a high price. If the enrollment stalls and others catch up, we could be dead in the water or, at best, in the middle of a dogfight. Some of our competitors have good profiles, even if I think ours is better.
Send CYDY a message on their website. We need to keep management's feet to the fire. We also need to know where we stand. Finally, we also need a higher stock price. Good enrollment means we'll be where we need to be.
.
3
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...
Continue Reading
What's Fueling the Market's Climb? I tell ya, sodium silicate might not be a household name, but it's trekking upwards with a clear purpose. By 2031, this market's expected to touch $7.4 billion from $6 billion in 2026 at a neat 4.4% CAGR. For an old-school trader like me, that's the kind of steady growth that catches my eye. The driving factors? Well, it’s more than...
Continue Reading
Navigating College Choices: More Than Just a Hunch When it comes to picking the right college, a lot of folks think it's like shooting in the dark—it's more than just a blind dart throw at a life map. According to a new report from the College Board, aligning with the right academic institution isn't merely a nice-to-have deal; it fundamentally shifts the odds in favor...
Continue Reading
Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...
Continue Reading
More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...
Continue Reading
Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...
Continue Reading
Breaking Updates Trump UX Changes Here's the real scoop: software updates that break functionality are setting companies back more than those user experience (UX) tweaks that folks gripe about but usually muddle through. According to a recent LITSLINK study, even three figures that supposedly quantify UX losses turn out to be questionable at best. Real-world Disasters:...
Continue Reading
Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...
Continue Reading
An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...
Continue Reading
Why Life Changes Demand an Insurance Review The nitty-gritty of life doesn't sit still—marriages, babies, job changes, and home deals or steals each bring their own clutter to the table. One thing's for sure: when your life shifts, your insurance ought to keep pace. Insurance Agent Nick Hogan drops the dime in the latest HelloNation article, laying it bare why...
Continue Reading
